Variation in initial kidney replacement therapy for end‐stage renal disease due to lupus nephritis in the United States
Open Access
- 4 November 2011
- journal article
- lupus
- Published by Wiley in Arthritis Care & Research
- Vol. 63 (12), 1642-1653
- https://doi.org/10.1002/acr.20607
Abstract
Objective Little is known about the patterns of use of initial kidney replacement therapies among patients with lupus nephritis (LN) end‐stage renal disease (ESRD). We aimed to identify sociodemographic and clinical factors associated with variation in initial kidney replacement therapies among LN ESRD patients. Methods Patients with incident LN ESRD (1995–2006) were identified in the US Renal Data System. Age, sex, race, ethnicity, medical insurance, employment status, residential region, clinical factors, and comorbidities were considered as potential predictors of ESRD treatment choice, i.e., peritoneal dialysis (PD), hemodialysis (HD), or preemptive kidney transplantation in age‐adjusted and multivariable‐adjusted logistic regression analyses. Results Of the 11,317 individuals with incident LN ESRD, 82.0% initiated HD, 12.2% initiated PD, and 2.8% underwent preemptive kidney transplantation. Receiving initial PD was significantly associated with earlier calendar year, female sex, higher albumin and hemoglobin levels, and lower serum creatinine levels. African Americans (versus whites), Medicaid beneficiaries and those with no health insurance (versus private insurance), and those unemployed (versus employed) had significantly reduced PD initiation. Comorbidities including congestive heart failure, peripheral vascular disease, and the inability to ambulate were also associated with decreased PD. Many sociodemographic and clinical factors favoring PD were associated with preemptive kidney transplant (versus dialysis) as well. Conclusion Few patients with LN ESRD receive initial PD or preemptive kidney transplantation. Race, ethnicity, employment, and medical insurance type are strongly associated with initial kidney replacement therapy choice. Future studies need to investigate the appropriateness of sociodemographic and clinical variation and the comparative effectiveness of kidney replacement therapies for LN ESRD.This publication has 51 references indexed in Scilit:
- Racial Ethnic Differences in Rates and Determinants of Deceased Donor Kidney TransplantationJournal of the American Society of Nephrology, 2011
- Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Arthritis & Rheumatism, 2011
- Discrepancy between Medical Evidence Form 2728 and Renal Biopsy for Glomerular DiseasesClinical Journal of the American Society of Nephrology, 2010
- Age, Race, Diabetes, Blood Pressure, and Mortality among Hemodialysis PatientsJournal of the American Society of Nephrology, 2010
- Recurrence of Lupus Nephritis after Kidney TransplantationJournal of the American Society of Nephrology, 2010
- Geographic and Temporal Trends in Peritoneal Dialysis Services in the United States Between 1995 and 2003American Journal of Kidney Diseases, 2010
- Influence of predialysis comorbidity and damage accrual on mortality in lupus patients treated with peritoneal dialysisLupus, 2010
- Changes in the Incidence of Endstage Renal Disease Due to Lupus Nephritis in the United States, 1996–2004The Journal of Rheumatology, 2009
- Factors affecting kidney‐transplant outcome in recipients with lupus nephritisClinical Transplantation, 2007
- The Effect of Patients' Preferences on Racial Differences in Access to Renal TransplantationThe New England Journal of Medicine, 1999